Sands Capital Ventures as of March 31, 2022
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 18 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Com Cl A (PATH) | 17.2 | $82M | 3.8M | 21.59 | |
| Nu Holdings Com Cl A (NU) | 14.7 | $71M | 9.1M | 7.72 | |
| Doordash Com Cl A (DASH) | 14.7 | $71M | 602k | 117.19 | |
| Dice Therapeutics | 12.6 | $60M | 3.1M | 19.13 | |
| Snowflake Com Cl A (SNOW) | 10.3 | $49M | 215k | 229.13 | |
| Samsara Com Cl B | 9.1 | $44M | 2.7M | 16.02 | |
| Karuna Therapeutics Ord | 7.1 | $34M | 268k | 126.79 | |
| Cincor Pharma | 3.5 | $17M | 950k | 17.54 | |
| Acumen Pharmaceuticals (ABOS) | 2.8 | $13M | 3.4M | 3.91 | |
| Olink Hldg Ab (OLK) | 1.6 | $7.5M | 426k | 17.66 | |
| 908 Devices (MASS) | 1.3 | $6.2M | 326k | 19.01 | |
| Samsara Com Cl A (IOT) | 1.1 | $5.2M | 326k | 16.02 | |
| Taysha Gene Therapies (TSHA) | 1.0 | $4.7M | 725k | 6.52 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $4.4M | 260k | 16.82 | |
| Repligen Corporation (RGEN) | 0.9 | $4.2M | 23k | 188.08 | |
| Candel Therapeutics (CADL) | 0.9 | $4.1M | 812k | 5.09 | |
| Spruce Biosciences (SPRB) | 0.3 | $1.6M | 787k | 2.01 | |
| Absci Corp (ABSI) | 0.1 | $487k | 58k | 8.43 |
